Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | $18.1M | $23.3M |
| Revenue growth | — | — | 28.7% |
| Gross profit | — | $1.77M | -$6.43M |
| Gross margin | — | 9.7% | -27.5% |
| Operating income | -$2.88M | -$6.15M | -$93.7M |
| Operating margin | — | -33.9% | -401.7% |
| Net income | -$2.90M | -$6.86M | -$101M |
| Net margin | — | -37.8% | -433.9% |
| EPS (diluted) | -$0.06 | -$0.15 | -$1.43 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$349K | -$1.22M | -$10.9M |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $1.36K | $1.03M | $42.6K |
| Total assets | $338K | $57.3M | $30.5M |
| Total liabilities | $3.24M | $50.6M | $42.9M |
| Long-term debt | — | $11.5M | $12.6M |
| Shareholders' equity | -$2.90M | $6.73M | -$12.4M |
| Retained earnings | -$2.90M | -$9.76M | -$111M |
| Shares (wtd avg diluted) | 44.7M | 47.3M | 71.0M |
Every figure is extracted from Wellgistics Health, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.